1. Effect of atorvastatin on plasma fibrinogen;Wierzbicki;Lancet,1998
2. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia;Bakker-Arkema;JAMA,1996
3. Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolaemia;Davidson;Am J Cardiol,1997
4. Changes in haemorrheology and atherothrombotic parameters by improving serum lipids in atorvastatin-treated hyperlipidaemics. In: 66th Congress of the European Atherosclerosis Society (Florence, July 13–17, 1996);Dujovne,1996